Literature DB >> 20231544

A-kinase anchoring proteins: getting to the heart of the matter.

John D Scott1, Luis F Santana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20231544      PMCID： PMC3014256          DOI： 10.1161/CIRCULATIONAHA.109.896357

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  109 in total

Review 1.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

2.  Distinct enzyme combinations in AKAP signalling complexes permit functional diversity.

Authors:  Naoto Hoshi; Lorene K Langeberg; John D Scott
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

Review 3.  Heterotrimeric G protein activation by G-protein-coupled receptors.

Authors:  William M Oldham; Heidi E Hamm
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

Review 4.  Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins.

Authors:  P C Gray; J D Scott; W A Catterall
Journal:  Curr Opin Neurobiol       Date:  1998-06       Impact factor: 6.627

5.  Differential effects of subunit interactions on protein kinase A- and C-mediated phosphorylation of L-type calcium channels.

Authors:  T S Puri; B L Gerhardstein; X L Zhao; M B Ladner; M M Hosey
Journal:  Biochemistry       Date:  1997-08-05       Impact factor: 3.162

6.  Abnormal intrastore calcium signaling in chronic heart failure.

Authors:  Zuzana Kubalova; Dmitry Terentyev; Serge Viatchenko-Karpinski; Yoshinori Nishijima; Inna Györke; Radmila Terentyeva; Daise N Q da Cuñha; Arun Sridhar; David S Feldman; Robert L Hamlin; Cynthia A Carnes; Sandor Györke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

Review 9.  cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.

Authors:  Manuela Zaccolo
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel.

Authors:  Samvit Tandan; Yanggan Wang; Thomas T Wang; Nan Jiang; Duane D Hall; Johannes W Hell; Xiang Luo; Beverly A Rothermel; Joseph A Hill
Journal:  Circ Res       Date:  2009-05-28       Impact factor: 17.367
View more
  32 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  PDE8A runs interference to limit PKA inhibition of Raf-1.

Authors:  Donald H Maurice
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

Review 3.  Calcineurin-dependent ion channel regulation in heart.

Authors:  Yanggan Wang; Samvit Tandan; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-07-01       Impact factor: 6.677

4.  Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.

Authors:  Lei Li; Jing Li; Benjamin M Drum; Yi Chen; Haifeng Yin; Xiaoyun Guo; Stephen W Luckey; Merle L Gilbert; G Stanley McKnight; John D Scott; L Fernando Santana; Qinghang Liu
Journal:  Cardiovasc Res       Date:  2016-11-17       Impact factor: 10.787

5.  AKAP150 participates in calcineurin/NFAT activation during the down-regulation of voltage-gated K(+) currents in ventricular myocytes following myocardial infarction.

Authors:  Madeline Nieves-Cintrón; Dinesh Hirenallur-Shanthappa; Patrick J Nygren; Simon A Hinke; Mark L Dell'Acqua; Lorene K Langeberg; Manuel Navedo; Luis F Santana; John D Scott
Journal:  Cell Signal       Date:  2015-12-24       Impact factor: 4.315

6.  Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes.

Authors:  Lianghui Zhang; Sundeep Malik; Grant G Kelley; Michael S Kapiloff; Alan V Smrcka
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

Review 7.  A kinase-anchoring proteins and adenylyl cyclase in cardiovascular physiology and pathology.

Authors:  Riad Efendiev; Carmen W Dessauer
Journal:  J Cardiovasc Pharmacol       Date:  2011-10       Impact factor: 3.105

8.  Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes.

Authors:  Zeineb Haj Slimane; Ibrahim Bedioune; Patrick Lechêne; Audrey Varin; Florence Lefebvre; Philippe Mateo; Valérie Domergue-Dupont; Matthias Dewenter; Wito Richter; Marco Conti; Ali El-Armouche; Jin Zhang; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Cardiovasc Res       Date:  2014-02-18       Impact factor: 10.787

9.  AKAP150-dependent cooperative TRPV4 channel gating is central to endothelium-dependent vasodilation and is disrupted in hypertension.

Authors:  Swapnil K Sonkusare; Thomas Dalsgaard; Adrian D Bonev; David C Hill-Eubanks; Michael I Kotlikoff; John D Scott; Luis F Santana; Mark T Nelson
Journal:  Sci Signal       Date:  2014-07-08       Impact factor: 8.192

10.  Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.

Authors:  Delphine Mika; Pierre Bobin; Martine Pomérance; Patrick Lechêne; Ruth E Westenbroek; William A Catterall; Grégoire Vandecasteele; Jérôme Leroy; Rodolphe Fischmeister
Journal:  Cardiovasc Res       Date:  2013-08-09       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.